Stereotactic Irradiation: Linear Accelerator and Gamma Knife

Clinical Radiation Oncology: Third Edition

Volumn , Issue , 2012, Pages 331-343

  McHaffie, Derek R ^a   Khuntia, Deepak ^b   Suh, John H ^c   Tomé, Wolfgang ^a   Mehta, Minesh P ^d  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Western Radiation Oncology   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84966738280     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-1637-5.00017-1     Document Type: Chapter

References (152)

1. Leksell L The stereotaxic method and radiosurgery of the brain. Acta Chir Scand 1951, 102(4):316-319.
2. Leksell L [Trigeminal neuralgia. Some neurophysiologic aspects and a new method of therapy.]. Lakartidningen 1971, 68(45):5145-5148.
3. Stieber VW, Bourland JD, Tome WA, Mehta MP Gentlemen (and ladies), choose your weapons. Gamma knife vs. linear accelerator radiosurgery. Technol Cancer Res Treat 2003, 2(2):79-86.
4. Mehta M, Noyes W, Craig B, et al. A cost-effectiveness and cost-utility analysis of radiosurgery vs. resection for single-brain metastases. Int J Radiat Oncol Biol Phys 1997, 39(2):445-454.
5. Larson DA, Bova F, Eisert D, et al. Current radiosurgery practice. Results of an ASTRO survey. Task Force on Stereotactic Radiosurgery, American Society for Therapeutic Radiology and Oncology. Int J Radiat Oncol Biol Phys 1994, 28(2):523-526.
6. Kubsad SS, Mackie TR, Gehring MA, et al. Monte Carlo and convolution dosimetry for stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 1990, 19(4):1027-1035.
7. Schell M, Bova F, Larson V AAPM Report 54. Stereotactic radiosurgery. Am Assoc Physicist Med 1995.
8. Friedman WA, Bova FJ The University of Florida radiosurgery system. Surg Neurol 1989, 32(5):334-342.
9. Mehta MP The physical, biologic, and clinical basis of radiosurgery. Curr Probl Cancer 1995, 19(5):265-329.
10. Prise KM, Schettino G, Folkard M, Held KD New insights on cell death from radiation exposure. Lancet Oncol 2005, 6(7):520-528.
11. Fuks Z, Kolesnick R Engaging the vascular component of the tumor response. Cancer Cell 2005, 8(2):89-91.
12. Park C, Papiez L, Zhang S, et al. Universal survival curve and single fraction equivalent dose. Useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys 2008, 70(3):847-852.
13. Stafford SL, Pollock BE, Foote RL, et al. Meningioma radiosurgery. Tumor control, outcomes, and complications among 190 consecutive patients. Neurosurgery 2001, 49(5):1029-1037. discussion 1037-1038.
14. Kondziolka D, Niranjan A, Lunsford LD, Flickinger JC Stereotactic radiosurgery for meningiomas. Neurosurg Clin North Am 1999, 10(2):317-325.
15. Lee JY, Niranjan A, McInerney J, et al. Stereotactic radiosurgery providing long-term tumor control of cavernous sinus meningiomas. J Neurosurg 2002, 97(1):65-72.
16. Kollova A, Liscak R, Novotny J, et al. Gamma Knife surgery for benign meningioma. J Neurosurg 2007, 107(2):325-336.
17. Nagele T, Petersen D, Klose U, et al. The "dural tail" adjacent to meningiomas studied by dynamic contrast-enhanced MRI. A comparison with histopathology. Neuroradiology 1994, 36(4):303-307.
18. Leber KA, Bergloff J, Pendl G Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 1998, 88(1):43-50.
19. Cai R, Barnett GH, Novak E, et al. Principal risk of peritumoral edema after stereotactic radiosurgery for intracranial meningioma is tumor-brain contact interface area. Neurosurgery 2010, 66(3):513-522.
20. Kondziolka D, Flickinger JC, Perez B Judicious resection and/or radiosurgery for parasagittal meningiomas. Outcomes from a multicenter review. Gamma Knife Meningioma Study Group. Neurosurgery 1998, 43(3):405-413. discussion 413-414.
21. Patil CG, Hoang S, Borchers DJ, et al. Predictors of peritumoral edema after stereotactic radiosurgery of supratentorial meningiomas. Neurosurgery 2008, 63(3):435-440. discussion 440-442.
22. Kreil W, Luggin J, Fuchs I, et al. Long term experience of gamma knife radiosurgery for benign skull base meningiomas. J Neurol Neurosurg Psychiatry 2005, 76(10):1425-1430.
23. Kondziolka D, Mathieu D, Lunsford LD, et al. Radiosurgery as definitive management of intracranial meningiomas. Neurosurgery 2008, 62(1):53-58. discussion 58-60.
24. Nikolopoulos TP, O'Donoghue GM Acoustic neuroma management. An evidence-based medicine approach. Otol Neurotol 2002, 23(4):534-541.
25. Flickinger JC, Kondziolka D, Niranjan A, et al. Acoustic neuroma radiosurgery with marginal tumor doses of 12 to 13 Gy. Int J Radiat Oncol Biol Phys 2004, 60(1):225-230.
26. Bhandare N, Jackson A, Eisbruch A, et al. Radiation therapy and hearing loss. Int J Radiat Oncol Biol Phys 2010, 76(3 Suppl):S50-S57.
27. Yang I, Sughrue ME, Han SJ, et al. A comprehensive analysis of hearing preservation after radiosurgery for vestibular schwannoma. J Neurosurg 2010, 112(4):851-859.
28. Myrseth E, Pedersen PH, Moller P, Lund-Johansen M Treatment of vestibular schwannomas. Why, when and how?. Acta Neurochir (Wien) 2007, 149(7):647-660. discussion 660.
29. Yang I, Sughrue ME, Han SJ, et al. Facial nerve preservation after vestibular schwannoma Gamma Knife radiosurgery. J Neurooncol 2009, 93(1):41-48.
30. Paek SH, Chung HT, Jeong SS, et al. Hearing preservation after gamma knife stereotactic radiosurgery of vestibular schwannoma. Cancer 2005, 104(3):580-590.
31. Linskey ME Hearing preservation in vestibular schwannoma stereotactic radiosurgery. What really matters?. J Neurosurg 2008, 109(Suppl):129-136.
32. Pollock BE, Driscoll CL, Foote RL, et al. Patient outcomes after vestibular schwannoma management. A prospective comparison of microsurgical resection and stereotactic radiosurgery. Neurosurgery 2006, 59(1):77-85.
33. Regis J, Pellet W, Delsanti C, et al. Functional outcome after gamma knife surgery or microsurgery for vestibular schwannomas. J Neurosurg 2002, 97(5):1091-1100.
34. Myrseth E, Moller P, Pedersen PH, Lund-Johansen M Vestibular schwannoma. Surgery or gamma knife radiosurgery? A prospective, nonrandomized study. Neurosurgery 2009, 64(4):654-661. discussion 661-663.
35. Pollock BE, Lunsford LD, Kondziolka D, et al. Outcome analysis of acoustic neuroma management. A comparison of microsurgery and stereotactic radiosurgery. Neurosurgery 1995, 36(1):215-224. discussion 224-229.
36. Karpinos M, Teh BS, Zeck O, et al. Treatment of acoustic neuroma. Stereotactic radiosurgery vs. microsurgery. Int J Radiat Oncol Biol Phys 2002, 54(5):1410-1421.
37. Meijer OW, Vandertop WP, Baayen JC, Slotman BJ Single-fraction vs. fractionated linac-based stereotactic radiosurgery for vestibular schwannoma. A single-institution study. Int J Radiat Oncol Biol Phys 2003, 56(5):1390-1396.
38. Andrews DW, Suarez O, Goldman HW, et al. Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas. Comparative observations of 125 patients treated at one institution. Int J Radiat Oncol Biol Phys 2001, 50(5):1265-1278.
39. Combs SE, Welzel T, Schulz-Ertner D, et al. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas. Int J Radiat Oncol Biol Phys 2010, 76(1):193-200.
40. Mayo C, Martel MK, Marks LB, et al. Radiation dose-volume effects of optic nerves and chiasm. Int J Radiat Oncol Biol Phys 2010, 76(3 Suppl):S28-S35.
41. Sheehan JP, Kondziolka D, Flickinger J, Lunsford LD Radiosurgery for residual or recurrent nonfunctioning pituitary adenoma. J Neurosurg 2002, 97(5 Suppl):408-414.
42. Fernandez A, Brada M, Zabuliene L, et al. Radiation-induced hypopituitarism. Endocr Relat Cancer 2009, 16(3):733-772.
43. Tinnel BA, Henderson MA, Witt TC, et al. Endocrine response after gamma knife-based stereotactic radiosurgery for secretory pituitary adenoma. Stereotact Funct Neurosurg 2008, 86(5):292-296.
44. Landolt AM, Haller D, Lomax N, et al. Stereotactic radiosurgery for recurrent surgically treated acromegaly. Comparison with fractionated radiotherapy. J Neurosurg 1998, 88(6):1002-1008.
45. Landolt AM, Lomax N Gamma knife radiosurgery for prolactinomas. J Neurosurg 2000, 93(Suppl 3):14-18.
46. Pollock BE, Nippoldt TB, Stafford SL, et al. Results of stereotactic radiosurgery in patients with hormone-producing pituitary adenomas. Factors associated with endocrine normalization. J Neurosurg 2002, 97(3):525-530.
47. Shaw E, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases. Final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 2000, 47(2):291-298.
48. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases. Phase III results of the RTOG 9508 randomised trial. Lancet 2004, 363(9422):1665-1672.
49. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990, 322(8):494-500.
50. Kalkanis SN, Kondziolka D, Gaspar LE, et al. The role of surgical resection in the management of newly diagnosed brain metastases. A systematic review and evidence-based clinical practice guideline. J Neurooncol 2010, 96(1):33-43.
51. Rades D, Kueter JD, Veninga T, et al. Whole brain radiotherapy plus stereotactic radiosurgery (WBRT+SRS) versus surgery plus whole brain radiotherapy (OP+WBRT) for 1-3 brain metastases. Results of a matched pair analysis. Eur J Cancer 2009, 45(3):400-404.
52. Sneed PK, Suh JH, Goetsch SJ, et al. A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 2002, 53(3):519-526.
53. Chidel MA, Suh JH, Reddy CA, et al. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases. Int J Radiat Oncol Biol Phys 2000, 47(4):993-999.
54. Sneed PK, Lamborn KR, Forstner JM, et al. Radiosurgery for brain metastases. Is whole brain radiotherapy necessary?. Int J Radiat Oncol Biol Phys 1999, 43(3):549-558.
55. Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases. A randomized controlled trial. JAMA 2006, 295(21):2483-2491.
56. Regine WF, Huhn JL, Patchell RA, et al. Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases. Results and implications. Int J Radiat Oncol Biol Phys 2002, 52(2):333-338.
57. Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation. A randomised controlled trial. Lancet Oncol 2009, 10(11):1037-1044.
58. Li J, Bentzen SM, Renschler M, Mehta MP Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol 2007, 25(10):1260-1266.
59. Souhami L, Seiferheld W, Brachman D, et al. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme. Report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys 2004, 60(3):853-860.
60. Romanelli P, Conti A, Pontoriero A, et al. Role of stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of recurrent glioblastoma multiforme. Neurosurg Focus 2009, 27(6):E8.
61. Hsieh PC, Chandler JP, Bhangoo S, et al. Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme. Neurosurgery 2005, 57(4):684-692. discussion 692.
62. Larson DA, Gutin PH, McDermott M, et al. Gamma knife for glioma. Selection factors and survival. Int J Radiat Oncol Biol Phys 1996, 36(5):1045-1053.
63. Sirin S, Kondziolka D, Niranjan A, et al. Prospective staged volume radiosurgery for large arteriovenous malformations. Indications and outcomes in otherwise untreatable patients. Neurosurgery 2008, 62(Suppl 2):744-754.
64. Flickinger JC, Pollock BE, Kondziolka D, Lunsford LD A dose-response analysis of arteriovenous malformation obliteration after radiosurgery. Int J Radiat Oncol Biol Phys 1996, 36(4):873-879.
65. Karlsson B, Lindquist C, Steiner L Prediction of obliteration after gamma knife surgery for cerebral arteriovenous malformations. Neurosurgery 1997, 40(3):425-430. discussion 30-31.
66. Lunsford LD, Kondziolka D, Flickinger JC, et al. Stereotactic radiosurgery for arteriovenous malformations of the brain. J Neurosurg 1991, 75(4):512-524.
67. Karlsson B, Lax I, Soderman M Risk for hemorrhage during the 2-year latency period following gamma knife radiosurgery for arteriovenous malformations. Int J Radiat Oncol Biol Phys 2001, 49(4):1045-1051.
68. Maruyama K, Kawahara N, Shin M, et al. The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations. N Engl J Med 2005, 352(2):146-153.
69. Maesawa S, Salame C, Flickinger JC, et al. Clinical outcomes after stereotactic radiosurgery for idiopathic trigeminal neuralgia. J Neurosurg 2001, 94(1):14-20.
70. Bradley K, Tome W, Resnick D, Mehta M Treatment of trigeminal neuralgia using linear accelerator-based radiosugery 2004, Karger, Basel.
71. Lopez BC, Hamlyn PJ, Zakrzewska JM Stereotactic radiosurgery for primary trigeminal neuralgia. State of the evidence and recommendations for future reports. J Neurol Neurosurg Psychiatry 2004, 75(7):1019-1024.
72. Riesenburger RI, Hwang SW, Schirmer CM, et al. Outcomes following single-treatment Gamma Knife surgery for trigeminal neuralgia with a minimum 3-year follow-up. J Neurosurg 2010, 112(4):766-771.
73. Flickinger JC, Pollock BE, Kondziolka D, et al. Does increased nerve length within the treatment volume improve trigeminal neuralgia radiosurgery? A prospective double-blind, randomized study. Int J Radiat Oncol Biol Phys 2001, 51(2):449-454.
74. Hasegawa T, Kondziolka D, Spiro R, et al. Repeat radiosurgery for refractory trigeminal neuralgia. Neurosurgery 2002, 50(3):494-500. discussion 552.
75. Pollock BE, Foote RL, Stafford SL, et al. Results of repeated gamma knife radiosurgery for medically unresponsive trigeminal neuralgia. J Neurosurg 2000, 93(Suppl 3):162-164.
76. Cheuk AV, Chin LS, Petit JH, et al. Gamma knife surgery for trigeminal neuralgia. Outcome, imaging, and brainstem correlates. Int J Radiat Oncol Biol Phys 2004, 60(2):537-541.
77. Kano H, Kondziolka D, Mathieu D, et al. Stereotactic radiosurgery for intractable cluster headache. An initial report from the North American Gamma Knife Consortium. J Neurosurg Apr 30, 2010, [Epub ahead of print].
78. McClelland S, Tendulkar RD, Barnett GH, et al. Long-term results of radiosurgery for refractory cluster headache. Neurosurgery 2006, 59(6):1258-1262. discussion 1262-1263.
79. Blomgren H, Lax I, Naslund I, Svanstrom R Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995, 34(6):861-870.
80. Haffty BG, Goldberg NB, Gerstley J, et al. Results of radical radiation therapy in clinical stage I, technically operable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1988, 15(1):69-73.
81. Wisnivesky JP, Bonomi M, Henschke C, et al. Radiation therapy for the treatment of unresected stage I-II non-small cell lung cancer. Chest 2005, 128(3):1461-1467.
82. Baumann P, Nyman J, Hoyer M, et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009, 27(20):3290-3296.
83. Fakiris AJ, McGarry RC, Yiannoutsos CT, et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma. Four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009, 75(3):677-682.
84. Onishi H, Shirato H, Nagata Y, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007, 2(7 Suppl 3):S94-S100.
85. Uematsu M, Shioda A, Suda A, et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer. A 5-year experience. Int J Radiat Oncol Biol Phys 2001, 51(3):666-670.
86. Lagerwaard FJ, Haasbeek CJ, Smit EF, et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008, 70(3):685-692.
87. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005, 63(5):1427-1431.
88. Timmerman R, Papiez L, McGarry R, et al. Extracranial stereotactic radioablation. Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003, 124(5):1946-1955.
89. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010, 303(11):1070-1076.
90. Grills IS, Mangona VS, Welsh R, et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol 2010, 28(6):928-935.
91. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006, 24(30):4833-4839.
92. Chang JY, Balter PA, Dong L, et al. Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008, 72(4):967-971.
93. Rusthoven KE, Kavanagh BD, Burri SH, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 2009, 27(10):1579-1584.
94. Rusthoven KE, Kavanagh BD, Cardenes H, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009, 27(10):1572-1578.
95. Okunieff P, Petersen AL, Philip A, et al. Stereotactic body radiation therapy (SBRT) for lung metastases. Acta Oncol 2006, 45(7):808-817.
96. Lee MT, Kim JJ, Dinniwell R, et al. Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 2009, 27(10):1585-1591.
97. Katz AW, Carey-Sampson M, Muhs AG, et al. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys 2007, 67(3):793-798.
98. Norihisa Y, Nagata Y, Takayama K, et al. Stereotactic body radiotherapy for oligometastatic lung tumors. Int J Radiat Oncol Biol Phys 2008, 72(2):398-403.
99. Gerszten PC, Germanwala A, Burton SA, et al. Combination kyphoplasty and spinal radiosurgery. A new treatment paradigm for pathological fractures. J Neurosurg Spine 2005, 3(4):296-301.
100. Gerszten PC, Burton SA, Ozhasoglu C, Welch WC Radiosurgery for spinal metastases. Clinical experience in 500 cases from a single institution. Spine (Phila Pa 1976) 2007, 32(2):193-199.
101. Chang EL, Shiu AS, Lii MF, et al. Phase I clinical evaluation of near-simultaneous computed tomographic image-guided stereotactic body radiotherapy for spinal metastases. Int J Radiat Oncol Biol Phys 2004, 59(5):1288-1294.
102. Schell M, Bova F, Larson V AAPM Report 54. Stereotactic radiosurgery. Am Assoc Physicist Med 1995, Available at. http://www.health.gov/paguidelines/.
103. Prise KM, Schettino G, Folkard M, Held KD New insights on cell death from radiation exposure. Lancet Oncol 2005, 6(7):520-528.
104. Fuks Z, Kolesnick R Engaging the vascular component of the tumor response. Cancer Cell 2005, 8(2):89-91.
105. Stafford SL, Pollock BE, Foote RL, et al. Meningioma radiosurgery. Tumor control, outcomes, and complications among 190 consecutive patients. Neurosurgery 2001, 49(5):1029-1037. discussion 1037-1038.
106. Lee JY, Niranjan A, McInerney J, et al. Stereotactic radiosurgery providing long-term tumor control of cavernous sinus meningiomas. J Neurosurg 2002, 97(1):65-72.
107. Kollova A, Liscak R, Novotny J, et al. Gamma Knife surgery for benign meningioma. J Neurosurg 2007, 107(2):325-336.
108. Nagele T, Petersen D, Klose U, et al. The "dural tail" adjacent to meningiomas studied by dynamic contrast-enhanced MRI. A comparison with histopathology. Neuroradiology 1994, 36(4):303-307.
109. Leber KA, Bergloff J, Pendl G Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 1998, 88(1):43-50.
110. Cai R, Barnett GH, Novak E, et al. Principal risk of peritumoral edema after stereotactic radiosurgery for intracranial meningioma is tumor-brain contact interface area. Neurosurgery 2010, 66(3):513-522.
111. Patil CG, Hoang S, Borchers DJ, et al. Predictors of peritumoral edema after stereotactic radiosurgery of supratentorial meningiomas. Neurosurgery 2008, 63(3):435-440. discussion 440-442.
112. Kondziolka D, Mathieu D, Lunsford LD, et al. Radiosurgery as definitive management of intracranial meningiomas. Neurosurgery 2008, 62(1):53-58. discussion 58-60.
113. Flickinger JC, Kondziolka D, Niranjan A, et al. Acoustic neuroma radiosurgery with marginal tumor doses of 12 to 13 Gy. Int J Radiat Oncol Biol Phys 2004, 60(1):225-230.
114. Linskey ME Hearing preservation in vestibular schwannoma stereotactic radiosurgery. What really matters?. J Neurosurg 2008, 109(Suppl):129-136.
115. Pollock BE, Driscoll CL, Foote RL, et al. Patient outcomes after vestibular schwannoma management. A prospective comparison of microsurgical resection and stereotactic radiosurgery. Neurosurgery 2006, 59(1):77-85.
116. Regis J, Pellet W, Delsanti C, et al. Functional outcome after gamma knife surgery or microsurgery for vestibular schwannomas. J Neurosurg 2002, 97(5):1091-1100.
117. Myrseth E, Moller P, Pedersen PH, Lund-Johansen M Vestibular schwannoma. Surgery or gamma knife radiosurgery? A prospective, nonrandomized study. Neurosurgery 2009, 64(4):654-661. discussion 661-663.
118. Meijer OW, Vandertop WP, Baayen JC, Slotman BJ Single-fraction vs. fractionated linac-based stereotactic radiosurgery for vestibular schwannoma. A single-institution study. Int J Radiat Oncol Biol Phys 2003, 56(5):1390-1396.
119. Andrews DW, Suarez O, Goldman HW, et al. Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas. Comparative observations of 125 patients treated at one institution. Int J Radiat Oncol Biol Phys 2001, 50(5):1265-1278.
120. Combs SE, Welzel T, Schulz-Ertner D, et al. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas. Int J Radiat Oncol Biol Phys 2010, 76(1):193-200.
121. Sheehan JP, Kondziolka D, Flickinger J, Lunsford LD Radiosurgery for residual or recurrent nonfunctioning pituitary adenoma. J Neurosurg 2002, 97(5 Suppl):408-414.
122. Landolt AM, Haller D, Lomax N, et al. Stereotactic radiosurgery for recurrent surgically treated acromegaly. Comparison with fractionated radiotherapy. J Neurosurg 1998, 88(6):1002-1008.
123. Pollock BE, Nippoldt TB, Stafford SL, et al. Results of stereotactic radiosurgery in patients with hormone-producing pituitary adenomas. Factors associated with endocrine normalization. J Neurosurg 2002, 97(3):525-530.
124. Shaw E, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases. Final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 2000, 47(2):291-298.
125. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases. Phase III results of the RTOG 9508 randomised trial. Lancet 2004, 363(9422):1665-1672.
126. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990, 322(8):494-500.
127. Rades D, Kueter JD, Veninga T, et al. Whole brain radiotherapy plus stereotactic radiosurgery (WBRT+SRS) versus surgery plus whole brain radiotherapy (OP+WBRT) for 1-3 brain metastases. Results of a matched pair analysis. Eur J Cancer 2009, 45(3):400-404.
128. Sneed PK, Suh JH, Goetsch SJ, et al. A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 2002, 53(3):519-526.
129. Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases. A randomized controlled trial. JAMA 2006, 295(21):2483-2491.
130. Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation. A randomised controlled trial. Lancet Oncol 2009, 10(11):1037-1044.
131. Li J, Bentzen SM, Renschler M, Mehta MP Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol 2007, 25(10):1260-1266.
132. Souhami L, Seiferheld W, Brachman D, et al. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme. Report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys 2004, 60(3):853-860.
133. Larson DA, Gutin PH, McDermott M, et al. Gamma knife for glioma. Selection factors and survival. Int J Radiat Oncol Biol Phys 1996, 36(5):1045-1053.
134. Flickinger JC, Pollock BE, Kondziolka D, Lunsford LD A dose-response analysis of arteriovenous malformation obliteration after radiosurgery. Int J Radiat Oncol Biol Phys 1996, 36(4):873-879.
135. Karlsson B, Lindquist C, Steiner L Prediction of obliteration after gamma knife surgery for cerebral arteriovenous malformations. Neurosurgery 1997, 40(3):425-430. discussion 30-31.
136. Karlsson B, Lax I, Soderman M Risk for hemorrhage during the 2-year latency period following gamma knife radiosurgery for arteriovenous malformations. Int J Radiat Oncol Biol Phys 2001, 49(4):1045-1051.
137. Maruyama K, Kawahara N, Shin M, et al. The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations. N Engl J Med 2005, 352(2):146-153.
138. Maesawa S, Salame C, Flickinger JC, et al. Clinical outcomes after stereotactic radiosurgery for idiopathic trigeminal neuralgia. J Neurosurg 2001, 94(1):14-20.
139. Riesenburger RI, Hwang SW, Schirmer CM, et al. Outcomes following single-treatment Gamma Knife surgery for trigeminal neuralgia with a minimum 3-year follow-up. J Neurosurg 2010, 112(4):766-771.
140. Flickinger JC, Pollock BE, Kondziolka D, et al. Does increased nerve length within the treatment volume improve trigeminal neuralgia radiosurgery? A prospective double-blind, randomized study. Int J Radiat Oncol Biol Phys 2001, 51(2):449-454.
141. Pollock BE, Foote RL, Stafford SL, et al. Results of repeated gamma knife radiosurgery for medically unresponsive trigeminal neuralgia. J Neurosurg 2000, 93(Suppl 3):162-164.
142. Kano H, Kondziolka D, Mathieu D, et al. Stereotactic radiosurgery for intractable cluster headache. An initial report from the North American Gamma Knife Consortium. J Neurosurg Apr 30, 2010, [Epub ahead of print].
143. Baumann P, Nyman J, Hoyer M, et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009, 27(20):3290-3296.
144. Onishi H, Shirato H, Nagata Y, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007, 2(7 Suppl 3):S94-S100.
145. Timmerman R, Papiez L, McGarry R, et al. Extracranial stereotactic radioablation. Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003, 124(5):1946-1955.
146. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010, 303(11):1070-1076.
147. Grills IS, Mangona VS, Welsh R, et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol 2010, 28(6):928-935.
148. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006, 24(30):4833-4839.
149. Chang JY, Balter PA, Dong L, et al. Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008, 72(4):967-971.
150. Rusthoven KE, Kavanagh BD, Burri SH, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 2009, 27(10):1579-1584.
151. Rusthoven KE, Kavanagh BD, Cardenes H, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009, 27(10):1572-1578.
152. Gerszten PC, Burton SA, Ozhasoglu C, Welch WC Radiosurgery for spinal metastases. Clinical experience in 500 cases from a single institution. Spine (Phila Pa 1976) 2007, 32(2):193-199.